Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05914311 · ClinicalTrials.gov registry record · NA
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT05914311 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 57 participants.
The verdict
NCT05914311, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
During the typical SCS trial the leads remain outside of the skin and can be prone to migration. The leads are typically secured in place with suture, tape, or a combination of both. This study will evaluate the amount of movement based on the method of being secured at the time of placement
Interventions
- DEVICE Suture
- DEVICE Suture and Dermabond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2023-09-08 |
| Est. Completion | 2025-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05914311
The ClinicalTrials.gov registry entry for NCT05914311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Suture is the first listed.
NCT05914311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05914311 about?
NCT05914311 is a clinical study titled "Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration". During the typical SCS trial the leads remain outside of the skin and can be prone to migration. The leads are typically secured in place with suture, tape, or a combination of both. This study will evaluate the amount of movement based on the method of being secured at the time of placement
What is the current status of trial NCT05914311?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2023-09-08. Estimated completion is 2025-02-26.
What interventions are being tested in trial NCT05914311?
The interventions under investigation include: Suture (DEVICE), Suture and Dermabond (DEVICE).
Who is sponsoring clinical trial NCT05914311?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.